FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004362273> ?p ?o ?g. }

• W2004362273 endingPage "21706" @default.
• W2004362273 startingPage "21701" @default.
• W2004362273 abstract "Several hundred phosphinic peptides having the general formula Z-(L,D)Pheψ(PO2CH2)(L,D)Xaa‘-Yaa‘-Zaa‘, where Xaa‘ = Gly or Ala and Yaa‘ and Zaa‘ represent 20 different amino acids, have been synthesized by the combinatorial chemistry approach. Peptide mixtures or individual peptides were evaluated for their ability to inhibit the rat brain zinc endopeptidases 24-15 and 24-16. Numerous phosphinic peptides of this series act as potent (Ki in the nanomolar range) mixed inhibitors of these two peptidases. However, our systematic and comparative strategy led us to delineate the residues located in P2′ and P3′ positions of the inhibitors that are preferred by these two peptidases. Thus, endopeptidase 24-15 exhibits a marked preference for inhibitors containing a basic residue (Arg or Lys) in the P2′ position, while 24-16 prefers a proline in this position. The P3′ position has less influence on the inhibitory potency and selectivity, both peptidases preferring a hydrophobic residue at this position. On the basis of these observations, we have prepared highly potent and selective inhibitors of endopeptidase 24-15. The Z-(L,D)Pheψ(PO2CH2)(L,D)Ala-Arg-Met compound (mixture of the four diastereoisomers) displays a Ki value of 70 pM for endopeptidase 24-15. The most selective inhibitor of endopeptidase 24-15 in this series, Z-(L,D)Pheψ(PO2CH2)(L,D)Ala-Arg-Phe, exhibits a Ki value of 0.160 nM and is more than 3 orders of magnitude less potent toward endopeptidase 24-16 (Ki = 530 nM). Furthermore, at 1 μM this selective inhibitor is unable to affect the activity of several other zinc peptidases, namely endopeptidase 24-11, angiotensin-converting enzyme, aminopeptidase M, leucine aminopeptidase, and carboxypeptidases A and B. Therefore, Z-(L,D)Pheψ(PO2CH2)(L,D)Ala-Arg-Phe can be considered as the most potent and specific inhibitor of endopeptidase 24-15 developed to date. This new inhibitor should be useful in assessing the contribution of this proteolytic activity in the physiological inactivation of neuropeptides known to be hydrolyzed, at least in vitro, by endopeptidase 24-15. Our study also demonstrates that the combinatorial chemistry approach leading to the development of phosphinic peptide libraries is a powerful strategy for discovering highly potent and selective inhibitors of zinc metalloproteases and should find a broader application in studies of this important class of enzymes. Several hundred phosphinic peptides having the general formula Z-(L,D)Pheψ(PO2CH2)(L,D)Xaa‘-Yaa‘-Zaa‘, where Xaa‘ = Gly or Ala and Yaa‘ and Zaa‘ represent 20 different amino acids, have been synthesized by the combinatorial chemistry approach. Peptide mixtures or individual peptides were evaluated for their ability to inhibit the rat brain zinc endopeptidases 24-15 and 24-16. Numerous phosphinic peptides of this series act as potent (Ki in the nanomolar range) mixed inhibitors of these two peptidases. However, our systematic and comparative strategy led us to delineate the residues located in P2′ and P3′ positions of the inhibitors that are preferred by these two peptidases. Thus, endopeptidase 24-15 exhibits a marked preference for inhibitors containing a basic residue (Arg or Lys) in the P2′ position, while 24-16 prefers a proline in this position. The P3′ position has less influence on the inhibitory potency and selectivity, both peptidases preferring a hydrophobic residue at this position. On the basis of these observations, we have prepared highly potent and selective inhibitors of endopeptidase 24-15. The Z-(L,D)Pheψ(PO2CH2)(L,D)Ala-Arg-Met compound (mixture of the four diastereoisomers) displays a Ki value of 70 pM for endopeptidase 24-15. The most selective inhibitor of endopeptidase 24-15 in this series, Z-(L,D)Pheψ(PO2CH2)(L,D)Ala-Arg-Phe, exhibits a Ki value of 0.160 nM and is more than 3 orders of magnitude less potent toward endopeptidase 24-16 (Ki = 530 nM). Furthermore, at 1 μM this selective inhibitor is unable to affect the activity of several other zinc peptidases, namely endopeptidase 24-11, angiotensin-converting enzyme, aminopeptidase M, leucine aminopeptidase, and carboxypeptidases A and B. Therefore, Z-(L,D)Pheψ(PO2CH2)(L,D)Ala-Arg-Phe can be considered as the most potent and specific inhibitor of endopeptidase 24-15 developed to date. This new inhibitor should be useful in assessing the contribution of this proteolytic activity in the physiological inactivation of neuropeptides known to be hydrolyzed, at least in vitro, by endopeptidase 24-15. Our study also demonstrates that the combinatorial chemistry approach leading to the development of phosphinic peptide libraries is a powerful strategy for discovering highly potent and selective inhibitors of zinc metalloproteases and should find a broader application in studies of this important class of enzymes." @default.
• W2004362273 created "2016-06-24" @default.
• W2004362273 creator A5004481123 @default.
• W2004362273 creator A5005286924 @default.
• W2004362273 creator A5029973604 @default.
• W2004362273 creator A5030471271 @default.
• W2004362273 creator A5030602183 @default.
• W2004362273 creator A5075033941 @default.
• W2004362273 creator A5089241337 @default.
• W2004362273 date "1995-09-01" @default.
• W2004362273 modified "2023-10-17" @default.
• W2004362273 title "Development of Highly Potent and Selective Phosphinic Peptide Inhibitors of Zinc Endopeptidase 24-15 Using Combinatorial Chemistry" @default.
• W2004362273 cites W1485637500 @default.
• W2004362273 cites W1530405712 @default.
• W2004362273 cites W1597912030 @default.
• W2004362273 cites W1791514122 @default.
• W2004362273 cites W1835492539 @default.
• W2004362273 cites W1854377422 @default.
• W2004362273 cites W1916309720 @default.
• W2004362273 cites W1969340813 @default.
• W2004362273 cites W1971728302 @default.
• W2004362273 cites W1972287167 @default.
• W2004362273 cites W1977620426 @default.
• W2004362273 cites W1983936315 @default.
• W2004362273 cites W1999299369 @default.
• W2004362273 cites W2003714053 @default.
• W2004362273 cites W2007817980 @default.
• W2004362273 cites W2012387984 @default.
• W2004362273 cites W2015036947 @default.
• W2004362273 cites W2041719513 @default.
• W2004362273 cites W2042759873 @default.
• W2004362273 cites W2055593299 @default.
• W2004362273 cites W2062555794 @default.
• W2004362273 cites W2071126869 @default.
• W2004362273 cites W2079556259 @default.
• W2004362273 cites W2085445331 @default.
• W2004362273 cites W2092634713 @default.
• W2004362273 cites W2093624098 @default.
• W2004362273 cites W2109075353 @default.
• W2004362273 cites W2110714098 @default.
• W2004362273 cites W2142759234 @default.
• W2004362273 cites W2170801299 @default.
• W2004362273 cites W2342639517 @default.
• W2004362273 cites W2364794409 @default.
• W2004362273 cites W2408011942 @default.
• W2004362273 cites W2412152374 @default.
• W2004362273 cites W2419561328 @default.
• W2004362273 cites W4253706013 @default.
• W2004362273 cites W44426163 @default.
• W2004362273 doi "https://doi.org/10.1074/jbc.270.37.21701" @default.
• W2004362273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7665587" @default.
• W2004362273 hasPublicationYear "1995" @default.
• W2004362273 type Work @default.
• W2004362273 sameAs 2004362273 @default.
• W2004362273 citedByCount "99" @default.
• W2004362273 countsByYear W20043622732012 @default.
• W2004362273 countsByYear W20043622732013 @default.
• W2004362273 countsByYear W20043622732014 @default.
• W2004362273 countsByYear W20043622732015 @default.
• W2004362273 countsByYear W20043622732017 @default.
• W2004362273 countsByYear W20043622732018 @default.
• W2004362273 countsByYear W20043622732019 @default.
• W2004362273 countsByYear W20043622732020 @default.
• W2004362273 countsByYear W20043622732021 @default.
• W2004362273 countsByYear W20043622732022 @default.
• W2004362273 crossrefType "journal-article" @default.
• W2004362273 hasAuthorship W2004362273A5004481123 @default.
• W2004362273 hasAuthorship W2004362273A5005286924 @default.
• W2004362273 hasAuthorship W2004362273A5029973604 @default.
• W2004362273 hasAuthorship W2004362273A5030471271 @default.
• W2004362273 hasAuthorship W2004362273A5030602183 @default.
• W2004362273 hasAuthorship W2004362273A5075033941 @default.
• W2004362273 hasAuthorship W2004362273A5089241337 @default.
• W2004362273 hasBestOaLocation W20043622731 @default.
• W2004362273 hasConcept C170493617 @default.
• W2004362273 hasConcept C181199279 @default.
• W2004362273 hasConcept C185592680 @default.
• W2004362273 hasConcept C2776775109 @default.
• W2004362273 hasConcept C2777774944 @default.
• W2004362273 hasConcept C2777803847 @default.
• W2004362273 hasConcept C2779281246 @default.
• W2004362273 hasConcept C2779809887 @default.
• W2004362273 hasConcept C2779815552 @default.
• W2004362273 hasConcept C2781063702 @default.
• W2004362273 hasConcept C2781338088 @default.
• W2004362273 hasConcept C515207424 @default.
• W2004362273 hasConcept C55493867 @default.
• W2004362273 hasConcept C60984968 @default.
• W2004362273 hasConcept C71240020 @default.
• W2004362273 hasConceptScore W2004362273C170493617 @default.
• W2004362273 hasConceptScore W2004362273C181199279 @default.
• W2004362273 hasConceptScore W2004362273C185592680 @default.
• W2004362273 hasConceptScore W2004362273C2776775109 @default.
• W2004362273 hasConceptScore W2004362273C2777774944 @default.
• W2004362273 hasConceptScore W2004362273C2777803847 @default.
• W2004362273 hasConceptScore W2004362273C2779281246 @default.
• W2004362273 hasConceptScore W2004362273C2779809887 @default.
• W2004362273 hasConceptScore W2004362273C2779815552 @default.

• next